ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2089 • 2015 ACR/ARHP Annual Meeting

    Netrin-1 and Its Receptors Unc5b and DCC May be Useful Targets for Preventing Multiple Myeloma Bone Lesions

    Aranzazu Mediero1, Tuere Wilder2 and Bruce Cronstein3, 1Medicine, Divison of Translational Medicine, NYU School of Medicine, New York City, NY, 2Dept of Med, Div of Rheum, NYU School of Medicine, New York, NY, 3Medicine, Division of Rheumatology, NYU School of Medicine, NEW YORK, NY

    Background/Purpose: Multiple Myeloma is characterized by the uncontrolled proliferation of plasma cells. This type of malignancy is particularly trophic to bone where it induces osteoclastic…
  • Abstract Number: 2090 • 2015 ACR/ARHP Annual Meeting

    Gender-Specific Pathways Linking Arthritis, Activity Limitation and Incident Heart Disease: A Causal Mediation Analysis of the Canadian Longitudinal National Population Health Survey

    Orit Schieir1, Sheilah. Hogg-Johnson1,2, Richard H Glazier3,4,5,6 and Elizabeth M. Badley1,7, 1Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 2Institute for Work and Health, Toronto, ON, Canada, 3Family and Community Medicine, St. Michael's Hospital, Toronto, ON, Canada, 4Centre for Research on Inner City Health, St. Michael's Hospital, Toronto, ON, Canada, 5Family and Community Medicine, University of Toronto, Toronto, ON, Canada, 6Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 7Division of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada

    Background/Purpose: Arthritis and activity limitation are risk factors for cardiovascular (CVD) morbidity and mortality. As arthritis is a major cause of activity limitation, the objective…
  • Abstract Number: 2091 • 2015 ACR/ARHP Annual Meeting

    Influence of Increasing Physical Activity on Longitudinal Changes in Disability Status Among Inactive Older Adults

    Jing Song1, Abigail Gilbert2, Rowland W. Chang3, Christine Pellegrini4, Linda S. Ehrlich-Jones5, Julia (Jungwha) Lee6, Daniel Pinto7, Pamela Semanik8, Leena Sharma9, C. Kent Kwoh10, Rebecca D. Jackson11 and Dorothy D. Dunlop12, 1Institute for Healthcare Studies, Northwestern University, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Dept Preventive Med, Northwestern Univ, Chicago, IL, 4Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Research CROR, Rehabilitation Institute Chicago, Chicago, IL, 6Department of Preventive Medicine, Biostatistics Collaboration Center, Northwestern University Feinberg School of Medicine, Chicago, IL, 7Department of Physical Therapy & Human Movement Sciences, Northwestern University, Chicago, IL, 8College of Nursing, Rush University, Chicago, IL, 9Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 10Rheumatology, University of Arizona, Tucson, AZ, 11Ohio State University, Columbus, OH, 12Inst Hlthcare Studies, Northwestern Univ, Chicago, IL

    Background/Purpose: An estimated 21% of disability attributed to arthritis is related to inactivity. This study analyzed data from the Osteoarthritis Initiative (OAI) to evaluate the…
  • Abstract Number: 2092 • 2015 ACR/ARHP Annual Meeting

    Knee Pain Burden Is Associated with Decreased Moderate to Vigorous Physical Activity: Data from the Osteoarthritis Initiative

    Javad Razjouyan1, Bijan Najafi2, Erin Ashbeck3, Dorothy D. Dunlop4, Julia (Jungwha) Lee5, Lynn Hamilton3 and C. Kent Kwoh6, 1Consortium on Advanced Motion Performance (iCAMP), Department of Surgery, University of Arizona, Tucson, AZ, 2Department of Surgery and Department of Biomedical Engineering, University of Arizona, Tucson, AZ, 3Arthritis Center, University of Arizona, Tucson, AZ, 4Institute for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Department of Preventive Medicine, Biostatistics Collaboration Center, Northwestern University Feinberg School of Medicine, Chicago, IL, 6Rheumatology, University of Arizona, Tucson, AZ

    Knee Pain Burden is Associated with Decreased Motor Performance: Data from the Osteoarthritis InitiativeBackground/Purpose: The influence of knee pain perception on daily life motor performance…
  • Abstract Number: 2093 • 2015 ACR/ARHP Annual Meeting

    Are General and Central Adiposity Associated with MRI-Assessed Structural Changes in the Knees of Older Adults?

    Tomoko Fujii1, Iva Miljkovic1, Robert M. Boudreau2, Ali Guermazi3, Sara R. Piva4, Elsa S. Strotmeyer2, Laura Carbone5, Tamara B. Harris6, Elisa A. Marques6, M Kyla Shea7, Michael C. Nevitt8, Anne B. Newman2 and C Kent Kwoh9, 1University of Pittsburgh, Pittsburgh, PA, 2Epidemiology, University of Pittsburgh, Pittsburgh, PA, 3Department of Radiology, Boston University School of Medicine, Boston, MA, 4Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 5Rheumatology, Georgia Regents University, Augusta, GA, 6National Institute on Aging, Bethesda, MD, 7Tuffs University, Boston, MA, 8Epidemiology and Biostatistics, UCSF, San Francisco, CA, 9University of Arizona, Tucson, AZ

    Background/Purpose: Obesity is one of the few modifiable risk factors of knee osteoarthritis (OA). However, it is not established whether a mechanical or metabolic mechanism…
  • Abstract Number: 2094 • 2015 ACR/ARHP Annual Meeting

    Identification of Gout Flare Using an Administrative Claims Based Algorithm

    Lindsey MacFarlane1, Daniel H. Solomon1 and Seoyoung C. Kim2, 1Rheumatology, Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology; Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Gout is a common inflammatory arthritis characterized by repeated acute flares. The ability to accurately identify gout flares is critical for comparative effectiveness studies…
  • Abstract Number: 2095 • 2015 ACR/ARHP Annual Meeting

    Dietary Patterns (DASH, Prudent, Western Diets) and the Risk of Gout in US Women – the Nurses Health Study

    Jeewoong Choi1, Na Lu2, Yuqing Zhang3, Sharan K. Rai4, Gary C. Curhan5 and Hyon K. Choi2, 1Massachusetts College of Pharmacy and Health Sciences, Boston, MA, 2Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 3BUSM, Boston, MA, 4Experimental Medicine, University of British Columbia, Vancouver, BC, Canada, 5Renal Division, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: There is a remarkable, rising disease burden of gout and associated cardiovascular-metabolic comorbidities (e.g., hypertension in 74% and obesity in 53% of cases in…
  • Abstract Number: 2096 • 2015 ACR/ARHP Annual Meeting

    Immune Dysregulation in Patients with TRNT1 Deficiency

    Angeliki Giannelou1, Qing Zhou2, Hong-Wei Sun3, Dan Yang4, Susan Moir5, Jehad H. Edwan3, Wanxia L. Tsai3, Elisavet Serti6, Monique Stoffels2, Deborah L. Stone7, Amanda K. Ombrello7, Karyl Barron5, Helen C. Su5, Abdullah Al Sonbul8, Sarita Joshi9, Kimberly Risma10, Lucie Sramkova11, Martha M. Quezado12, Katherine Calvo13, Abu-Asab Mones14, Gustavo Gutierrez-Cruz3, Massimo G. Gadina3, Markus Hafner3, Ivona Aksentijevich2,15 and Daniel Kastner2, 1National Human Genome Research Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2NIH/NHGRI, Metabolic, Cardiovascular, and Inflammatory Disease Genomics Branch, Bethesda, MD, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 5National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 6Immunology Section, Liver Diseases Branch, NIDDK, NIH, Bethesda, MD, 7National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 8King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia, 9Nationwide Children's Hospital, Columbus, OH, 10Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 11Charles University 2nd Faculty of Medicine and UH Motol, Prague, Czech Republic, 12Laboratory of Pathology/National Cancer Institute, National Institutes of Health, Bethesda, MD, 13Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, 14National Eye Institute, National Institutes of Health, Bethesda, MD, 15Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD

    Background/Purpose:   Next generation sequencing has led to the discovery of new diseases and molecules regulating immune function. Hypomorphic mutations in the TRNT1 gene cause a…
  • Abstract Number: 2097 • 2015 ACR/ARHP Annual Meeting

    HLA-B27 Expression Profoundly Shapes the Host-Microbiota Metabolome

    Mark Asquith1, Patrick Stauffer2, Sean Davin3, Stephen R. Planck4, Phoebe Lin5 and James T. Rosenbaum6, 1OHSU, Portland, OR, 2Oregon Health & Science University, Portland, OR, 3Oregon Health and Science University, Portland, OR, 4Casey Eye Institute, Oregon Health & Science University, Portland, OR, 5Casey Eye Institute, Oregon Health and Science University, Portland, OR, 6Devers Eye Institute, Legacy Hospital system, Portland, OR

    Background/Purpose: The intestinal microbiota plays a pivotal role in both host fitness and disease. Increasing evidence implicates microbial metabolites in the modulation of host immunity…
  • Abstract Number: 2098 • 2015 ACR/ARHP Annual Meeting

    Prioritizing Likely Causative Genes in Genome-Wide Association Studies (GWAS) Identified Risk Loci for Immune-Mediated Inflammatory Disorders Using Cell-Type Specific Expression Quantitative Loci (eQTL) Information

    Elisa Docampo1, Ming Fang1, Julia Dmitrieva1, Emilie Théâtre1, Mahmoud Elansary1, Rob Mariman1, Ann-Stephan Gori1, Myriam Mni1, François Crins2, Wouter Coppieters2, Edouard Louis3 and Michel Georges1, 1Unit of Animal Genomics, GIGA-R Université de Liège, Liège, Belgium, 2GenoTranscriptomics platform, GIGA-R Université de Liège, Liège, Belgium, 3Department of Gastroenterology, University Hospital CHU of Liège, Liège, Belgium

    <h1> Background/Purpose: </h1>  Immune-mediated inflammatory disorders (IMIDs) share many genetic risk factors. Pleiotropy may exist at different levels and most of the underlying mechanisms are…
  • Abstract Number: 2099 • 2015 ACR/ARHP Annual Meeting

    Genome-Wide Association Study of Clinically-Defined Gout Identifies Multiple Risk Loci: A Clue for Future Companion Diagnostics of Gout

    Hirotaka Matsuo1, Ken Yamamoto2, Hirofumi Nakaoka3, Akiyoshi Nakayama1, Masayuki Sakiyama1, Atsushi Takahashi4,5, Takahiro Nakamura6, Yusuke Kawamura1, Nobuyuki Hamajima7, Ituro Inoue8, Michiaki Kubo4, Kimiyoshi Ichida9, Hiroshi Ooyama10, Toru Shimizu11 and Nariyoshi Shinomiya1, 1Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan, 2Department of Medical Chemistry, Kurume University School of Medicine, Kurume, Japan, 3Division of Human Genetics, Department of Integrated Genetics, National Institute of Genetics, Mishima, Japan, 4Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan, 5Research Center, National Cerebral and Cardiovascular Center, Suita, Japan, 6National Defense Medical College, Laboratory for Mathematics, Tokorozawa, Japan, 7Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan, 8Department of Integrated Genetics, National Institute of Genetics, Mishima, Japan, 9Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan, 10Ryougoku East Gate Clinic, Tokyo, Japan, 11Midorigaoka Hospital, Takatsuki, Japan

    Background/Purpose: Gout, caused by hyperuricaemia, is a multifactorial disease. Recently, genome-wide association studies (GWASs) of gout have been reported; however, they included self-reported gout cases.…
  • Abstract Number: 2100 • 2015 ACR/ARHP Annual Meeting

    Hypomethylation in Enhancer and Promoter Regions of Interferon Regulated Genes in Multiple Tissues Is Associated with Primary Sjögren’s Syndrome

    Juliana Imgenberg-Kreuz1, Johanna K Sandling1,2, Jonas Carlsson Almlöf1, Jessica Nordlund1, Linnea Signér2, Katrine B Norheim3, Roald Omdal3, Majia-Leena Eloranta2, Lars Rönnblom2, Ann-Christine Syvänen1 and Gunnel Nordmark2, 1Molecular Medicine and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 2Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 3Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway

    Background/Purpose: Epigenetic modifications have emerged as important contributing factors in the pathogenesis of autoimmune diseases, including primary Sjögren’s syndrome (pSS), and may act as a…
  • Abstract Number: 2101 • 2015 ACR/ARHP Annual Meeting

    HLA Associations in Mothers of Children with Cardiac Manifestations of Neonatal Lupus

    Hannah C. Ainsworth1, Carl D. Langefeld1, Miranda C. Marion2, Nathalie Costedoat-Chalumeau3, Antonio Brucato4, Jill P. Buyon5 and Robert M. Clancy5, 1Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 2Biostatistical Sciences and Center for Public Health Genomics, Wake Forest University Health Sciences, Winston-Salem, NC, 3Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France, 4Internal Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy, 5Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY

    Background/Purpose: Cardiac manifestations of neonatal lupus, comprising atrioventricular conduction defects and cardiomyopathy, occur in fetuses exposed to anti-Ro/SSA antibodies, and carry substantial mortality. There is…
  • Abstract Number: 2102 • 2015 ACR/ARHP Annual Meeting

    Higher Persistence and Adherence with Combination Therapy with Tumor Necrosis Factor Inhibitor+Methotrexate Combination Versus Triple Therapy in US Veterans with Rheumatoid Arthritis

    Brian Sauer1, Chia-Chen Teng2, Jianwei Leng3, Ted R. Mikuls4, Jeffrey R. Curtis5, Bradley S. Stolshek6, Derek Tang6 and Grant W. Cannon7, 1IDEAS Center and Division of Epidemiology, HSR&D SLC VA Medical Center and University of Utah, Salt Lake City, UT, 2HSR&D SLC VA Medical Center and University of Utah, Salt Lake City, UT, 3Internal Medicine Division of Epidemiology, HSR&D SLC VA Medical Center and University of Utah, Salt Lake City, UT, 4University of Nebraska Medical Center, Omaha, NE, 5University of Alabama at Birmingham, Birmingham, AL, 6Amgen, Inc., Thousand Oaks, CA, 7Division of Rheumatology, Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT

    Background/Purpose: Randomized controlled trials in RA have reported efficacy with both triple therapy (methotrexate [MTX] + hydroxychloroquine [HCQ] + sulfasalazine [SSZ]) and tumor necrosis factor…
  • Abstract Number: 2103 • 2015 ACR/ARHP Annual Meeting

    Temporal Trends in Drug Prescription, Utilization and Costs Among Rheumatoid Arthritis (RA) Patients Show Wide Regional Variation Despite Universal Drug Coverage

    Mark Tatangelo1, Michael Paterson2, George A. Tomlinson3, Nick Bansback4, Jessica Widdifield5, Tara Gomes2 and Claire Bombardier6, 1University of Toronto, Toronto, ON, Canada, 2Institute of Clinical Evaluative Sciences, Toronto, ON, Canada, 3Medicine, Mount Sinai Hospital, Toronto, ON, Canada, 4Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada, 5University Health Network, Toronto, ON, Canada, 618 Strathearn Blvd, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Monitoring of drug use and costs can: describe trends in expenditures over time, identify regional variations in access and indicate physicians' uptake of best-practice…
  • « Previous Page
  • 1
  • …
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology